Baptist Health Adopts Innovative AI Solutions, Cutting-Edge Research to Address Complexities of Care
The rapid progress in oncology, along with complex cases and rising costs, presents challenges in delivering high-quality cancer care.
Mark A. Davis, MD, MS
Advertisement
Articles by Mark A. Davis, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Long-Term OMNIVORE Data Show Durable Treatment-Free Survival in RCC
2
De-Escalated Neoadjuvant HER2-Targeted Therapy Shows Durable 5-Year Survival
3
Behind the FDA Approval: Isatuximab On-Body Injector Supports ‘Patient-Centric’ Priorities in Multiple Myeloma
4
Phase 3 ENHANCE Trial: Magrolimab Adds Toxicity, Not Benefit, in MDS
5